Results for tag: "Chronic Plaque Psoriasis Drug"

The Chronic Plaque Psoriasis Drug market is a subset of the larger Psoriasis Drugs market. Psoriasis is a chronic, inflammatory skin condition that affects millions of people worldwide. Chronic Plaque Psoriasis is the most common form of psoriasis, characterized by red, scaly patches on the skin. Treatment for Chronic Plaque Psoriasis typically involves topical medications, phototherapy, and systemic medications. Topical medications are applied directly to the skin and are often the first line of treatment. Phototherapy involves exposing the skin to ultraviolet light to reduce inflammation and slow the growth of skin cells. Systemic medications are taken orally or injected and are used to reduce inflammation and slow the growth of skin cells. The Chronic Plaque Psoriasis Drug market includes a variety of companies that produce medications for the treatment of psoriasis. These companies include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Show Less Read more